To include your compound in the COVID-19 Resource Center, submit it here.

Acura gains after FDA approves Oxecta

Acura Pharmaceuticals Inc. (NASDAQ:ACUR) gained $0.63 (16%) to $4.50 on Monday after FDA approved an NDA from partner

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE